根据一份提交给美国证券交易委员会（SEC）的文件显示，爱尔兰高等法院已确定将于2026年2月10日，就Avadel Pharmaceuticals plc针对Alkermes公司所提出的一项安排计划举行听证会。这一关键的法律程序日程，标志着两家制药公司之间一项重要 corporate 行动的推进进入了新的阶段。
根据一份提交给美国证券交易委员会（SEC）的文件显示，爱尔兰高等法院已确定将于2026年2月10日，就Avadel Pharmaceuticals plc针对Alkermes公司所提出的一项安排计划举行听证会。这一关键的法律程序日程，标志着两家制药公司之间一项重要 corporate 行动的推进进入了新的阶段。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.